|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The role of the growth arrest - specific homeobox gene gax in inhibiting angiogenesis and nuclear factor- kappaB signaling显示文摘 | Patel S Chen Y Sohail H | 2006 | Surg Res2006，130，2： | 1 |
| 2 | N - terminal pro - B - type natriuretic peptide complements the GRACE risk score in predic- ting early and late mortality following acute coronary syndrome 显示文摘 | Sohail QK Hafid N Kelvin H | 2009 | Clin Sci2009，117，： | 1 |
| 3 | Effect of different levels of blood meal on broiler performance during two phases growth显示文摘 | Tabinda K Noor N A Sohail H K | 2007 | International Journal of Poultry Science2007，6，12： | 1 |
| 4 | Faraday-effect Magnetometry:Compensation for the Temperature-dependent Verdet Con-stant显示文摘 | SOHAIL H Z RAIPH P T | 1994 | Science Technology1994，，5： | 1 |
| 5 | Rhizobium,Bradyrhizobium and Agrobacterium strains isolated from cultivated legumes显示文摘 | SOHAIL H SUMERA Y KAUSER A M | 2004 | Biology and Fertility of Soils2004，39，3： | 1 |
| 6 | Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections显示文摘 | Sohail M R Uslan D Z Khan A H | 2007 | J Am Cell Cardiol2007，49，18： | 1 |
| 7 | N-terminal pro-B-type natriuretic peptide com plem ents the GRACE risk score in predicting early and late mortality following acute coronary syndrome显示文摘 | SOHAIL Q K HAFID N KELVIN H | 2009 | Clin Sci2009，117，： | 1 |
| 8 | Ion Permeation Dynamics in Carbon Nanotubes显示文摘 | Liu H Sohail M Jameson C J | 2006 | J Chem Phys2006，125，08： | 1 |
| 9 | Management and outcome of permanent pacemaker and implantable cardiover-defibrillator infections显示文摘 | Sohail M R Uslan D Z Khan A H | 2007 | J Am Coll Cardiol2007，49，18： | 1 |
| 10 | Measurements of combustion properties in a microwave en- hanced flame 显示文摘 | Emanuel S Stockman Sohail H Zaidi Richard B Miles | 2009 | Combustion and Flame2009，156，7： | 1 |
| 11 | Kinetics of batch single cell protein production from rice pohshings with Candida utilis in continuously aerated tank reactors显示文摘 | Ibrahim M R Sohail H K Jabbar M A | 2006 | Bioresource Technology2006，97，： | 1 |
| 12 | Anatomic Comparison of Two Transobturator Tape Procedures显示文摘 | CHRISTOPHER MZ SOHAIL S SANDRA H | 2007 | Obstet Gynecol2007，109，3： | 1 |
| 13 | Management and outcome of permanent pacemaker and implautable cardiovertor defibrillator infections显示文摘 | SOHAIL M R USLAN D Z KHAN A H | 2007 | J Am Coil Cardiol2007，49，14： | 1 |
| 14 | Anatomic comparison of two transobturator tape procedures 显示文摘 | Christopher MZ Sohail S Sandra H | 2007 | Obstetrics & Gynecology2007，109，3： | 1 |
| 15 | Determinants of service quality in the hospitality industry:the case of Malaysian Hotels显示文摘 | Sohail M.Sadiq Roy Matthew H Saeed Mohammad Ahmed Zafar U | | 0，，： | 1 |
| 16 | N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome显示文摘 | Sohail Q Hafid Kelvin H N G | 2009 | Clinical Science2009，117，1： | 1 |
| 17 | Magnetohydrodynamic Power Generation using Externally Ionized, Cold, Supersonic Air as Working Fluid 显示文摘 | Robert C Murray Sohail H Zaidi Mario R Carraro | 2006 | AIAA Journal2006，44，1： | 1 |
| 18 | Effect of dietary supplementation of mannan-oligosaccharides and Lactobacillus-based probiotics on indigenous intestinal bacterial ecology and intestinal microarehiteeture of broilers reared under heat stress显示文摘 | Sohail M U Ahmad I Rehman H | 2010 | Journal of Dairy Science2010，1，： | 1 |
| 19 | Impact of metabolic dysfunction-associated steatotic liver disease on COVID-19 hospitalizations:A propensity-matched analysis of the United States显示文摘BACKGROUND Metabolic dysfunction-associated steatotic liver disease(MASLD),formally known as nonalcoholic fatty liver disease,is the most common chronic liver disease in the United States.Patients with MASLD have been reported to be at a higher risk of developing severe coronavirus disease 2019(COVID-19)and death.However,most studies are single-center studies,and nationwide data in the AIM To study the influence of MASLD on COVID-19 hospitalizations during the initial phase of the pandemic.METHODS We retrospectively analyzed the 2020 National Inpatient Sample(NIS)database to identify primary COVID-19 hospitalizations based on an underlying diagnosis of MASLD.A matched comparison cohort of COVID-19 hospit-alizations without MASLD was identified from NIS after 1:N propensity score matching based on gender,race,and comorbidities,including hypertension,heart failure,diabetes,and cirrhosis.The primary outcomes included inpatient mortality,length of stay,and hospitalization costs.Secondary outcomes included the prevalence of systemic complications.RESULTS A total of 2210 hospitalizations with MASLD were matched to 2210 hospitalizations without MASLD,with a good comorbidity balance.Overall,there was a higher prevalence of severe disease with more intensive care unit admissions(9.5%vs 7.2%,P=0.007),mechanical ventilation(7.2%vs 5.7%,P=0.03),and septic shock(5.2%vs 2.7%,P<0.001)in the MASLD cohort than in the non-MASLD cohort.However,there was no difference in mortality(8.6%vs 10%,P=0.49),length of stay(5 d vs 5 d,P=0.25),and hospitalization costs(42081.5$vs 38614$,P=0.15)between the MASLD and non-MASLD cohorts.CONCLUSION The presence of MAFLD with or without liver cirrhosis was not associated with increased mortality in COVID-19 hospitalizations;however,there was an increased incidence of severe COVID-19 infection.This data(2020)predates the availability of COVID-19 vaccines,and many MASLD patients have since been vaccinated.It will be interesting to see if these trends are present in the subsequent years of the pandemic. | Abdullah Sohail Hassam Ali Pratik Patel Subanandhini Subramanium Dushyant Singh Dahiya Amir H Sohail Manesh Kumar Gangwani Sanjaya K Satapathy | 2024 | World Journal of Virology2024，13，1： | 0 |
| 20 | Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions显示文摘Fecal microbiota transplantation(FMT)offers a potential treatment avenue for hepatic encephalopathy(HE)by leveraging beneficial bacterial displacement to restore a balanced gut microbiome.The prevalence of HE varies with liver disease severity and comorbidities.HE pathogenesis involves ammonia toxicity,gut-brain communication disruption,and inflammation.FMT aims to restore gut microbiota balance,addressing these factors.FMT's efficacy has been explored in various conditions,including HE.Studies suggest that FMT can modulate gut microbiota,reduce ammonia levels,and alleviate inflammation.FMT has shown promise in alcohol-associated,hepatitis B and C-associated,and non-alcoholic fatty liver disease.Benefits include improved liver function,cognitive function,and the slowing of disease progression.However,larger,controlled studies are needed to validate its effectiveness in these contexts.Studies have shown cognitive improvements through FMT,with potential benefits in cirrhotic patients.Notably,trials have demonstrated reduced serious adverse events and cognitive enhancements in FMT arms compared to the standard of care.Although evidence is promising,challenges remain:Limited patient numbers,varied dosages,administration routes,and donor profiles.Further large-scale,controlled trials are essential to establish standardized guidelines and ensure FMT's clinical applications and efficacy.While FMT holds potential for HE management,ongoing research is needed to address these challenges,optimize protocols,and expand its availability as a therapeutic option for diverse hepatic conditions. | Yash R Shah Hassam Ali Angad Tiwari David Guevara-Lazo Natalia Nombera-Aznaran Bhanu Siva Mohan Pinnam Manesh Kumar Gangwani Harishankar Gopakumar Amir H Sohail SriLakshmiDevi Kanumilli Ernesto Calderon-Martinez Geetha Krishnamoorthy Nimish Thakral Dushyant Singh Dahiya | 2024 | World Journal of Hepatology2024，16，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员